Lexicon Pharmaceuticals
LXRX
#7434
Rank
S$0.56 B
Marketcap
S$1.55
Share price
1.69%
Change (1 day)
58.83%
Change (1 year)

P/S ratio for Lexicon Pharmaceuticals (LXRX)

P/S ratio as of January 2026 (TTM): 6.23

According to Lexicon Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.67. At the end of 2025 the company had a P/S ratio of 7.18.

P/S ratio history for Lexicon Pharmaceuticals from 2001 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20257.18-20.19%
20249.00-97.11%
2023311-88.01%
2022> 100031.73%
2021> 10009661.37%
202020.21372.78%
20191.37-87.63%
201811.1-4.13%
201711.5-33.11%
201617.362.75%
201510.6-63.22%
201428.8-93.06%
2013416-60.01%
2012> 1000341.36%
2011236137.98%
201099.0254.62%
200927.9371.12%
20085.93-28.35%
20078.27114.35%
20063.8623.92%
20053.11-60.96%
20047.97-7.68%
20038.6422.76%
20027.04258.18%
20011.96

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Eterna Therapeutics
ERNA
> 1000 157,365.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
5.64-9.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
3.66-41.29%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
3.39-45.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
5.20-16.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
2.52-59.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
5.25-15.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
14.6 134.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
3.52-43.46%๐Ÿ‡บ๐Ÿ‡ธ USA